Page last updated: 2024-10-25

clenbuterol and Muscular Dystrophy, Animal

clenbuterol has been researched along with Muscular Dystrophy, Animal in 9 studies

Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.

Muscular Dystrophy, Animal: MUSCULAR DYSTROPHY that occurs in VERTEBRATE animals.

Research Excerpts

ExcerptRelevanceReference
"Clenbuterol treatment significantly increased the relative mass (P<0."1.30Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol. ( Hayes, A; Williams, DA, 1998)
"Clenbuterol treatment was associated with a 30-40% increase in fatigability in DIA and SOL muscles of control and mdx mice at both ages."1.29Beneficial versus adverse effects of long-term use of clenbuterol in mdx mice. ( Dupont-Versteegden, EE; Katz, MS; McCarter, RJ, 1995)
"5."1.29Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. ( Hayes, A; Williams, DA, 1994)
"Clenbuterol was given in the drinking water (1."1.29Exercise and clenbuterol as strategies to decrease the progression of muscular dystrophy in mdx mice. ( Dupont-Versteegden, EE, 1996)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's6 (66.67)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dupont-Versteegden, EE2
Katz, MS1
McCarter, RJ1
Hayes, A2
Williams, DA2
Zeman, RJ2
Zhang, Y1
Etlinger, JD2
Turner, PR1
Schultz, R1
Ganguly, B1
Steinhardt, RA1
Peng, H1
Danon, MJ1
Lynch, GS1
Hinkle, RT1
Faulkner, JA1
Rothwell, NJ1
Stock, MJ1

Other Studies

9 other studies available for clenbuterol and Muscular Dystrophy, Animal

ArticleYear
Beneficial versus adverse effects of long-term use of clenbuterol in mdx mice.
    Muscle & nerve, 1995, Volume: 18, Issue:12

    Topics: Animals; Clenbuterol; Diaphragm; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Muscle Fatigue; Mus

1995
Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.
    Clinical and experimental pharmacology & physiology, 1994, Volume: 21, Issue:10

    Topics: Animals; Body Weight; Clenbuterol; Dystrophin; Heart; Histocytochemistry; Isometric Contraction; Mal

1994
Clenbuterol, a beta 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle.
    The American journal of physiology, 1994, Volume: 267, Issue:3 Pt 1

    Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Gamma Rays; Hindlimb; Male; Mice; Mice, Inbred mdx;

1994
Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle.
    The Journal of membrane biology, 1993, Volume: 133, Issue:3

    Topics: Animals; Calcium; Calcium Channels; Calpain; Cells, Cultured; Clenbuterol; Dose-Response Relationshi

1993
Exercise and clenbuterol as strategies to decrease the progression of muscular dystrophy in mdx mice.
    Journal of applied physiology (Bethesda, Md. : 1985), 1996, Volume: 80, Issue:3

    Topics: Animals; Clenbuterol; Mice; Mice, Inbred mdx; Muscle Fatigue; Muscle, Skeletal; Muscular Dystrophy,

1996
Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: I. Clenbuterol.
    Journal of the neurological sciences, 1998, May-07, Volume: 157, Issue:2

    Topics: Administration, Oral; Animals; Clenbuterol; Disease Models, Animal; Heart; Male; Mice; Mice, Mutant

1998
Clenbuterol reduces degeneration of exercised or aged dystrophic (mdx) muscle.
    Muscle & nerve, 2000, Volume: 23, Issue:4

    Topics: Adrenergic beta-Agonists; Aging; Animals; Clenbuterol; Humans; Mice; Mice, Inbred C57BL; Mice, Inbre

2000
Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
    Experimental physiology, 2000, Volume: 85, Issue:3

    Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Energy Metabolism; In Vitro Techniques;

2000
Modification of body composition by clenbuterol in normal and dystrophic (mdx) mice.
    Bioscience reports, 1985, Volume: 5, Issue:9

    Topics: Animals; Body Composition; Body Weight; Clenbuterol; Energy Metabolism; Ethanolamines; Female; Mice;

1985